A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Abstract Background Preeclampsia is a multisystem disorder characterized by vascular endothelial malfunction occurring after 20 weeks of gestation. Placental soluble fms-like tyrosine kinase-1 (sFlt-1) is an antiangiogenic factor and placental growth factor (PlGF) is a potent angiogenic factor. The...
Saved in:
Main Authors: | Vivek Pant (Author), Binod Kumar Yadav (Author), Jyoti Sharma (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PlGF, sFlt-1 and sFlt-1/PlGF ratio: Promising markers for predicting pre-eclampsia
by: Ola H El-Demerdash, et al.
Published: (2018) -
Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
by: Pooneh Nikuei, et al.
Published: (2020) -
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
by: Dietmar Schlembach, et al.
Published: (2018) -
The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
by: Risa Miyatake, et al.
Published: (2023) -
Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study
by: Satoshi Shinohara, et al.
Published: (2021)